Active Biotech (Sweden) Buy Hold or Sell Recommendation
| ACTI Stock | SEK 0.26 0.01 4.00% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Active Biotech AB is 'Strong Sell'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Active Biotech AB given historical horizon and risk tolerance towards Active Biotech. When Macroaxis issues a 'buy' or 'sell' recommendation for Active Biotech AB, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Active Biotech Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Active and provide practical buy, sell, or hold advice based on investors' constraints. Active Biotech AB. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Active |
Execute Active Biotech Buy or Sell Advice
The Active recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Active Biotech AB. Macroaxis does not own or have any residual interests in Active Biotech AB or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Active Biotech's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Insignificant | Details | |
Volatility | Out of control | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Moves completely opposite to the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Active Biotech Trading Alerts and Improvement Suggestions
| Active Biotech AB is way too risky over 90 days horizon | |
| Active Biotech AB has some characteristics of a very speculative penny stock | |
| Active Biotech AB appears to be risky and price may revert if volatility continues | |
| Active Biotech AB has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| Net Loss for the year was (49.83 M) with profit before overhead, payroll, taxes, and interest of 6.72 M. | |
| Active Biotech AB has accumulated about 53.13 M in cash with (46.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.11. | |
| Roughly 46.0% of the company shares are held by company insiders |
Active Biotech Returns Distribution Density
The distribution of Active Biotech's historical returns is an attempt to chart the uncertainty of Active Biotech's future price movements. The chart of the probability distribution of Active Biotech daily returns describes the distribution of returns around its average expected value. We use Active Biotech AB price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Active Biotech returns is essential to provide solid investment advice for Active Biotech.
| Mean Return | 1.30 | Value At Risk | -20.83 | Potential Upside | 27.78 | Standard Deviation | 26.61 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Active Biotech historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Active Biotech Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Active Biotech or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Active Biotech's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Active stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 1.85 | |
β | Beta against Dow Jones | -4.77 | |
σ | Overall volatility | 26.81 | |
Ir | Information ratio | 0.04 |
Active Biotech Volatility Alert
Active Biotech AB is showing large volatility of returns over the selected time horizon. Active Biotech AB is a potential penny stock. Although Active Biotech may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Active Biotech AB. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Active instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Active Biotech Fundamentals Vs Peers
Comparing Active Biotech's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Active Biotech's direct or indirect competition across all of the common fundamentals between Active Biotech and the related equities. This way, we can detect undervalued stocks with similar characteristics as Active Biotech or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Active Biotech's fundamental indicators could also be used in its relative valuation, which is a method of valuing Active Biotech by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Active Biotech to competition |
| Fundamentals | Active Biotech | Peer Average |
| Return On Equity | -1.44 | -0.31 |
| Return On Asset | -0.67 | -0.14 |
| Current Valuation | 224.92 M | 16.62 B |
| Shares Outstanding | 264.89 M | 571.82 M |
| Shares Owned By Insiders | 45.94 % | 10.09 % |
| Shares Owned By Institutions | 15.84 % | 39.21 % |
| Price To Earning | (8.47) X | 28.72 X |
| Price To Book | 5.63 X | 9.51 X |
| Price To Sales | 29.72 X | 11.42 X |
| Gross Profit | 6.72 M | 27.38 B |
| EBITDA | (48.52 M) | 3.9 B |
| Net Income | (49.83 M) | 570.98 M |
| Cash And Equivalents | 53.13 M | 2.7 B |
| Cash Per Share | 0.11 X | 5.01 X |
| Total Debt | 200 K | 5.32 B |
| Debt To Equity | 268.10 % | 48.70 % |
| Current Ratio | 1.37 X | 2.16 X |
| Book Value Per Share | 0.13 X | 1.93 K |
| Cash Flow From Operations | (46.17 M) | 971.22 M |
| Earnings Per Share | (0.25) X | 3.12 X |
| Target Price | 3.0 | |
| Number Of Employees | 9 | 18.84 K |
| Beta | 0.53 | -0.15 |
| Market Capitalization | 268.37 M | 19.03 B |
| Total Asset | 56.8 M | 29.47 B |
| Working Capital | 36 M | 1.48 B |
| Current Asset | 65 M | 9.34 B |
| Current Liabilities | 29 M | 7.9 B |
| Net Asset | 56.8 M |
Active Biotech Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Active . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 1.1 M | |||
| Daily Balance Of Power | 0.25 | |||
| Rate Of Daily Change | 1.04 | |||
| Day Median Price | 0.26 | |||
| Day Typical Price | 0.26 | |||
| Price Action Indicator | 0.005 | |||
| Period Momentum Indicator | 0.01 |
About Active Biotech Buy or Sell Advice
When is the right time to buy or sell Active Biotech AB? Buying financial instruments such as Active Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Active Biotech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Alternative Currency ETFs Thematic Idea Now
Alternative Currency ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Alternative Currency ETFs theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Alternative Currency ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Active Stock Analysis
When running Active Biotech's price analysis, check to measure Active Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Active Biotech is operating at the current time. Most of Active Biotech's value examination focuses on studying past and present price action to predict the probability of Active Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Active Biotech's price. Additionally, you may evaluate how the addition of Active Biotech to your portfolios can decrease your overall portfolio volatility.